Abiomed
ABMD
#1112
Rank
A$26.30 B
Marketcap
$583.35
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Earnings for Abiomed (ABMD)

Earnings in 2022 (TTM): A$0.49 Billion

According to Abiomed's latest financial reports the company's current earnings are A$1.07 Billion. In 2021 the company made an earning of A$0.28 Billion a decrease over its 2020 earnings that were of A$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Abiomed from 2013 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) A$0.49 B70.43%
2021 A$0.28 B-25.49%
2020 A$0.38 B-19.62%
2019 A$0.48 B48.14%
2018 A$0.32 B51%
2017 A$0.21 B71.85%
2016 A$0.12 B41.79%
2015 A$88.77 M187.69%
2014 A$30.85 M126.26%
2013 A$13.63 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.54 B 3.44%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.28 B 528.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$47.52 Million-109.10%๐Ÿ‡บ๐Ÿ‡ธ USA